Trial Profile
A Randomized, Controlled, Open-Label Tolerability And Efficacy Study Of TU-100 For The Treatment Of Postoperative Ileus In Patients Undergoing Laparotomy For Large Bowel Resection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs TU 100 (Primary)
- Indications Postoperative ileus
- Focus Adverse reactions
- Sponsors Tsumura
- 24 Sep 2014 New trial record